as 03-28-2025 4:00pm EST
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
Founded: | 1970 | Country: | United States |
Employees: | N/A | City: | CINCINNATI |
Market Cap: | 8.8B | IPO Year: | N/A |
Target Price: | $667.00 | AVG Volume (30 days): | 124.3K |
Analyst Decision: | Buy | Number of Analysts: | 1 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 19.89 | EPS Growth: | 10.93 |
52 Week Low/High: | $512.12 - $642.68 | Next Earning Date: | 04-23-2025 |
Revenue: | $2,431,287,000 | Revenue Growth: | 7.37% |
Revenue Growth (this year): | 8.46% | Revenue Growth (next year): | 6.64% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
MCNAMARA KEVIN J | CHE | president and CEO | Mar 6 '25 | Sell | $593.67 | 2,000 | $1,187,340.00 | 102,679 | |
LEE SPENCER S | CHE | executive vice president | Mar 3 '25 | Sell | $592.25 | 1,326 | $785,323.50 | 17,627 | |
Judkins Brian C | CHE | VP and Chief Legal Officer | Dec 30 '24 | Buy | $519.50 | 145 | $75,327.50 | 1,678 |
CHE Breaking Stock News: Dive into CHE Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
Zacks
8 days ago
StockStory
10 days ago
StockStory
17 days ago
MT Newswires
21 days ago
Simply Wall St.
21 days ago
Argus Research
24 days ago
Zacks
24 days ago
The information presented on this page, "CHE Chemed Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.